SM16, an Orally Active TGF-beta Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model.
Kai Fu,Michael J. Corbley,Lihong Sun,Jessica E. Friedman,Feng Shan,James L. Papadatos,Donald Costa,Frank Lutterodt,Harry Sweigard,Scott Bowes,Michael Choi,P. Ann Boriack-Sjodin,Robert M. Arduini,Dongyu Sun,Miki N. Newman,Xiamei Zhang,Jonathan N. Mead,Claudio E. Chuaqui,H. -Kam Cheung,Xin Zhang,Mark Cornebise,Mary Beth Carter,Serene Josiah,Juswinder Singh,Wen-Cherng Lee,Alan Gill,Leona E. Ling Arteriosclerosis, thrombosis, and vascular biology（2008）
关键词
TGF beta,restenosis,fibrosis,neointimal formation,activin
AI 理解论文
溯源树
样例
